Seborrheic dermatitis is more than dandruff or simple fungal overgrowth: this evidence map shows a recurrent inflammatory disease shaped by Malassezia dysbiosis, barrier/lipid dysfunction, immune activation, Staphylococcus signals, and psychosocial burden. The full SAIMSARA evidence map is worth reading because it separates stronger treatment signals — ketoconazole, ciclopirox, selenium disulfide, calcineurin inhibitors, isotretinoin, roflumilast foam, and barrier repair — from emerging or heterogeneous findings across 706 original studies.
Human-verified editorial review
Verified by World ID proof-of-human. This editorial layer was submitted from a SAIMSARA account verified as a unique human.
Abstract: To synthesize original research on seborrheic dermatitis, emphasizing recurrent pathophysiologic signals, epidemiology, diagnostic differentiation, comorbidities, quality-of-life burden, and therapeutic evidence relevant to clinical and research interpretation. The review uses 168 references and builds its evidence map from 706 original studies with 34354058 total participants (topic-deduplicated ΣN). The evidence synthesized here supports a multidimensional model of seborrheic dermatitis in which Malassezia-associated dysbiosis, barrier and lipid dysfunction, and host immune activation jointly drive a recurrent inflammatory phenotype rather than a single causal pathway. This framework is reinforced by the convergent benefit observed across antifungal, anti-inflammatory, keratolytic, and barrier-directed interventions, including newer options such as roflumilast foam with 76.0%–80.4% clear or almost clear outcomes through 52 weeks. Recurrent associations with metabolic, neurologic, ocular, and psychosocial burden, with quality-of-life impairment sometimes exceeding objective severity, indicate that management should extend beyond topical antimicrobial suppression alone. The main interpretive uncertainty remains heterogeneity in microbial, barrier, and host findings across populations and methods. Future longitudinal studies integrating microbiome, barrier, lipid, and immune profiling within the same patients across flare and remission cycles are needed to enable personalized, mechanism-aligned therapy.
Final search date and database lock: 2026-05-12 22:01:23 CEST
Plan: Pro (expanded craft tokens; source: PubMed)
Source: PubMed
Total Abstracts/Papers: 1962
Downloaded Abstracts/Papers: 1962
Included original and non-original Abstracts/Papers (all): 833
Included original Abstracts/Papers (Vote counting by direction of effect): 706
Reference Index (links used in paper): 168
Total participants (topic deduplicated ΣN): 34354058
Get access to the full paper
Unlock the full evidence map
The full evidence review, including the Introduction, Methods, Results, Discussion, Conclusion, figures, and complete reference index, opens after purchase or sign-in.
The Evidence Object JSON is a separate machine-readable evidence product: a concentrated synthesis of results, topic-level evidence, and discussion across original and non-original studies. It can be directly input into your LLM, agent, or RAG workflow.
[3] Efficacy, safety, and recurrence in seborrheic dermatitis: A dose-dependent analysis of oral isotretinoin (10 mg vs 20 mg). — https://doi.org/10.1016/j.jaad.2025.05.1376
[26] Effectiveness and tolerance of medicated shampoo containing selenium sulfide and salicylic acid in patients with seborrheic dermatitis. — https://doi.org/10.1080/09546634.2025.2506676
[36] Rosacea and seborrheic dermatitis differentially respond to lactic acid sting and capsaicin tests in Chinese women. — https://doi.org/10.1111/jocd.15878
[40] A study on dermatologists' self-assessment of the efficacy of a 1% selenium disulfide-0.9% salicylic acid -based shampoo for scalp seborrheic dermatitis. — https://doi.org/10.1007/s00403-025-04165-3
[64] Efficacy and safety of oral isotretinoin in the treatment of moderate to severe seborrheic dermatitis: a retrospective study. — https://doi.org/10.1111/ijd.16582
[75] A deep learning-based approach toward differentiating scalp psoriasis and seborrheic dermatitis from dermoscopic images. — https://doi.org/10.3389/fmed.2022.965423
[77] Dermoscopic findings in scalp psoriasis and seborrheic dermatitis; two new signs; signet ring vessel and hidden hair. — https://doi.org/10.4103/0019-5154.147786
[101] Staphylococcus aureus is the most common bacterial agent of the skin flora of patients with seborrheic dermatitis. — https://doi.org/10.5826/dpc.0802a04
[104] Clinical study on treatment of facial seborrheic dermatitis with intense pulsed light combined with 30% supramolecular salicylic acid. — https://doi.org/10.6061/clinics/2020/e1875
[109] Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial. — https://doi.org/10.1111/j.1461-1244.2004.02409.x
[111] Low-dose oral isotretinoin for moderate to severe seborrhea and seborrheic dermatitis: a randomized comparative trial. — https://doi.org/10.1111/ijd.13408
[114] Enhancing assisted diagnostic accuracy in scalp psoriasis: A Multi-Network Fusion Object Detection Framework for dermoscopic pattern diagnosis. — https://doi.org/10.1111/srt.13698
[116] Comparison the efficacy of fluconazole and terbinafine in patients with moderate to severe seborrheic dermatitis. — https://doi.org/10.1155/2014/705402
[117] Treatment of facial seborrheic dermatitis with pimecrolimus cream 1%: an open-label clinical study in Korean patients. — https://doi.org/10.3346/jkms.2007.22.5.868
[129] Correlation of Pityosporum ovale density with clinical severity of seborrheic dermatitis as assessed by a simplified technique. — https://doi.org/10.1016/0190-9622(90)70191-j
[144] Successful treatment of erythematous-squamous disorders of the external auditory canal with tacrolimus and clotrimazole in otic oil: Our experience in 25 patients. — https://doi.org/10.1111/dth.14471
[159] Dermatologic manifestations among human immunodeficiency virus patients in Morocco and association with immune status. — https://doi.org/10.1111/ijd.13864
[163] Efficacy of Topical Rosemary Extract Lotion versus Topical 2% Ketoconazole Lotion in the Treatment of Seborrheic Dermatitis: A Double-Blind Randomized Controlled Clinical Trial. — https://doi.org/10.5826/dpc.1404a242
[169] Exploring the phenomenon of social appearance anxiety in individuals suffering from seborrheic dermatitis: Comprehensive insights derived from a case-control study. — https://doi.org/10.14744/nci.2025.26928
[178] Blood levels of vitamin E, polyunsaturated fatty acids of phospholipids, lipoperoxides and glutathione peroxidase in patients affected with seborrheic dermatitis. — https://doi.org/10.1016/0923-1811(91)90064-5
[179] Masks trigger facial seborrheic dermatitis and psoriasis: evidence from a multicenter, case-control study during COVID-19 pandemic. — https://doi.org/10.23736/s2784-8671.22.07246-2
[197] The frequency of common skin conditions in preschool-aged children in Australia: seborrheic dermatitis and pityriasis capitis (cradle cap). — https://doi.org/10.1001/archderm.139.3.318
[205] Dermatologic Conditions in Down Syndrome: A Multi-Site Retrospective Review of International Classification of Diseases Codes. — https://doi.org/10.1111/pde.15757
[207] A Comparative Randomized Clinical Study Assessing the Efficacy of a 1% Selenium Disulfide-Based Shampoo versus 2% Ketoconazole Shampoo in Subjects with Moderate to Severe Scalp Seborrheic Dermatitis. — https://doi.org/10.1159/000539209
[211] Isolation and identification of Malassezia species from Chinese and Korean patients with seborrheic dermatitis and in vitro studies on their bioactivity on sebaceous lipids and IL-8 production. — https://doi.org/10.1111/myc.12456
[220] Ketoconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis. A double-blind comparative study. — https://doi.org/10.1016/s0190-9622(88)70244-3
[221] Multicenter, double-blind, parallel group study investigating the non-inferiority of efficacy and safety of a 2% miconazole nitrate shampoo in comparison with a 2% ketoconazole shampoo in the treatment of seborrhoeic dermatitis of the scalp. — https://doi.org/10.3109/09546634.2013.782092
[225] The psychosocial dimensions of seborrheic dermatitis: A cross-sectional study on anxiety, personality, and quality of life. — https://doi.org/10.1371/journal.pone.0331030
[226] Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis. — https://doi.org/10.1016/j.jaad.2006.11.007
[228] Randomized, open-labeled, non-inferiority study between ciclopiroxolamine 1% cream and ketoconazole 2% foaming gel in mild to moderate facial seborrheic dermatitis. — https://doi.org/10.1159/000068904
[229] Single-blind, randomized controlled trial evaluating the treatment of facial seborrheic dermatitis with hydrocortisone 1% ointment compared with tacrolimus 0.1% ointment in adults. — https://doi.org/10.1016/j.jaad.2011.02.032
[230] Investigation of the relationship between seborrheic dermatitis and metabolic syndrome parameters. — https://doi.org/10.1111/jocd.15121
[234] A comprehensive literature review and an international expert consensus on the management of scalp seborrheic dermatitis in adults. — https://doi.org/10.1684/ejd.2024.4703
[241] Novel and Off-Label Biologic Use in the Management of Hidradenitis Suppurativa, Pyoderma Gangrenosum, Lichen Planus, and Seborrheic Dermatitis: A Narrative Review. — https://doi.org/10.1007/s13555-022-00860-5
[256] An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face. — https://doi.org/10.1016/j.clindermatol.2009.09.002
[264] Investigating the role of dietary glycemic factors and antioxidant capacity, metabolic status, and oxidative stress in seborrheic dermatitis: A case-control study. — https://doi.org/10.1016/j.jaad.2024.10.078
[266] Selenium Disulfide-based shampoo applied for 4 weeks significantly improves dandruff and seborrheic dermatitis. — https://doi.org/10.1684/ejd.2023.4402
[303] Epidemiologic Study of Malassezia Yeasts in Seborrheic Dermatitis Patients by the Analysis of 26S rDNA PCR-RFLP. — https://doi.org/10.5021/ad.2010.22.2.149
[313] Lesional skin of seborrheic dermatitis patients is characterized by skin barrier dysfunction and correlating alterations in the stratum corneum ceramide composition. — https://doi.org/10.1111/exd.14952
[321] Modulating the skin mycobiome-bacteriome and treating seborrheic dermatitis with a probiotic-enriched oily suspension. — https://doi.org/10.1038/s41598-024-53016-0
[322] Reflectance confocal microscopy features of seborrheic dermatitis for plaque psoriasis differentiation. — https://doi.org/10.1159/000363289
[323] An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis. — https://doi.org/10.1080/09546630802286993
[324] Bidirectional Associations Between Seborrheic Dermatitis and Epithelial Barrier Diseases: A Retrospective Cohort Study. — https://doi.org/10.1111/all.70112
[328] Physical activity as a potential nonpharmacologic strategy to prevent seborrheic dermatitis: a cohort study in the UK biobank. — https://doi.org/10.1080/09546634.2026.2646001
[334] Prospective, Open-Label, Multi-Centre, Randomized Study to Compare the Effectiveness, Safety, and Tolerability of Lulican™ Shampoo Versus Ketoconazole Shampoo in Indian Adult Patients With Mild to Moderate Scalp Seborrheic Dermatitis (LEAD Study). — https://doi.org/10.7759/cureus.32035
[337] Maintenance effect of a once-weekly regimen of a Selenium Disulfide-based shampoo in moderate-to-severe scalp seborrheic dermatitis after initial treatment with topical corticosteroid/salicylic acid. — https://doi.org/10.1684/ejd.2023.4401
[347] Tacrolimus 0.1% versus ciclopiroxolamine 1% for maintenance therapy in patients with severe facial seborrheic dermatitis: A multicenter, double-blind, randomized controlled study. — https://doi.org/10.1016/j.jaad.2020.09.055
[348] Effects of a cream containing 5% hyaluronic acid mixed with a bacterial-wall-derived glycoprotein, glycyrretinic acid, piroctone olamine and climbazole on signs, symptoms and skin bacterial microbiota in subjects with seborrheic dermatitis of the face. — https://doi.org/10.2147/ccid.s205904
[351] The global, regional, and national burden of seborrheic dermatitis: results and insights from the Global Burden of Disease 2019 Study. — https://doi.org/10.1007/s00403-022-02469-2
[354] Clinical and instrumental evaluation of a new topical non-corticosteroid antifungal/anti-inflammatory/antiseborrheic combination cream for the treatment of mild-to-moderate facial seborrheic dermatitis. — https://doi.org/10.2147/ccid.s186621
[360] Hydrocortisone 1% cream and sertaconazole 2% cream to treat facial seborrheic dermatitis: A double-blind, randomized clinical trial. — https://doi.org/10.1016/j.ijwd.2016.11.008
[365] Efficacy of Oral Itraconazole in the Treatment and Relapse Prevention of Moderate to Severe Seborrheic Dermatitis: A Randomized, Placebo-Controlled Trial. — https://doi.org/10.1007/s40257-015-0133-9
[379] Exploring Anti-Fungal, Anti-Microbial and Anti-Inflammatory Properties of a Topical Non-Steroidal Barrier Cream in Face and Chest Seborrheic Dermatitis. — https://doi.org/10.1007/s13555-019-00339-w
[380] Psychiatric comorbidities and alexithymia in patients with seborrheic dermatitis: a questionnaire study in Turkey. — https://doi.org/10.1007/s40257-013-0019-7
[388] Assessing therapeutic effectiveness of scalp treatments for dandruff and seborrheic dermatitis, part 1: a reliable and relevant method based on the adherent scalp flaking score (ASFS). — https://doi.org/10.3109/09546634.2012.687089
[389] A Clinico-Etiological Study of Dermatoses in Pediatric Age Group in Tertiary Health Care Center in South Gujarat Region. — https://doi.org/10.4103/0019-5154.169147
[398] Malassezia intra-specific diversity and potentially new species in the skin microbiota from Brazilian healthy subjects and seborrheic dermatitis patients. — https://doi.org/10.1371/journal.pone.0117921
[402] A lipohydroxyacid-containing shampoo improves scalp condition and quality of life in patients with seborrheic dermatitis and light-to-moderate scalp psoriasis. — https://doi.org/10.1111/j.1473-2165.2009.00431.x
[415] Eczema, facial erythema, and seborrheic dermatitis symptoms among young adults in China in relation to ambient air pollution, climate, and home environment. — https://doi.org/10.1111/ina.12918
[429] Infantile eczema at one month of age is associated with cord blood eosinophilia and subsequent development of atopic dermatitis and wheezing illness until two years of age. — https://doi.org/10.1159/000085435
[430] Retrospective analysis of the relationship between infantile seborrheic dermatitis and atopic dermatitis. — https://doi.org/10.1111/pde.12216
[432] Molecular analysis of Malassezia microflora in seborrheic dermatitis patients: comparison with other diseases and healthy subjects. — https://doi.org/10.1038/sj.jid.5701017
[454] Long-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks. — https://doi.org/10.1007/s40257-025-00984-2
[461] Facial Dermatoses Associated With Mask-Wearing in the COVID-19 Era: A Nationwide, Cross-Sectional, Multicenter, Questionnaire-based Study. — https://doi.org/10.5021/ad.23.061
[475] Assessing Biophysical and Physiological Profiles of Scalp Seborrheic Dermatitis in the Thai Population. — https://doi.org/10.1155/2019/5128376
[476] The change in the frequency and severity of facial dermatoses and complaints in healthcare workers during the COVID-19. — https://doi.org/10.1111/jocd.15044
[507] Infections and Autoimmune Disorders of the Eyelids - Difficult Differential Diagnoses and Therapeutic Challenges. — https://doi.org/10.1055/a-2689-6204
